|
Originally published In Press as doi:10.1074/jbc.M108765200 on January 14, 2002
J. Biol. Chem., Vol. 277, Issue 12, 10512-10522, March 22, 2002
Protein Binding and Functional Characterization of Plakophilin
2
EVIDENCE FOR ITS DIVERSE ROLES IN DESMOSOMES AND -CATENIN
SIGNALING*
Xinyu
Chen ,
Stefan
Bonné§,
Mechthild
Hatzfeld¶,
Frans
van Roy§, and
Kathleen J.
Green
From the Departments of Pathology and
Dermatology and the Robert H. Lurie Cancer Center, Northwestern
University Medical School, Chicago, Illinois 60611, the
§ Molecular Cell Biology Unit, Department of Molecular
Biology, VIB-University of Ghent, Ledeganckstraat 35, B-9000 Ghent,
Belgium, and the ¶ Molecular Biology Group of the Medical
Faculty, University of Halle, 06097 Halle/Saale, Germany
Received for publication, September 11, 2001, and in revised form, December 18, 2001
 |
ABSTRACT |
Plakophilins are a subfamily of
p120-related arm-repeat proteins that can be found in both desmosomes
and the nucleus. Among the three known plakophilin members, plakophilin
1 has been linked to a genetic skin disorder and shown to play
important roles in desmosome assembly and organization. However, little
is known about the binding partners and functions of the most widely
expressed member, plakophilin 2. To better understand the cellular
functions of plakophilin 2, we have examined its protein interactions
with other junctional molecules using co-immunoprecipitation and yeast two-hybrid assays. Here we show that plakophilin 2 can interact directly with several desmosomal components, including desmoplakin, plakoglobin, desmoglein 1 and 2, and desmocollin 1a and 2a. The head
domain of plakophilin 2 is critical for most of these interactions and
is sufficient to direct plakophilin 2 to cell borders. In addition,
plakophilin 2 is less efficient than plakophilin 1 in localizing to the
nucleus and enhancing the recruitment of excess desmoplakin to cell
borders in transiently transfected COS cells. Furthermore, plakophilin
2 is able to associate with -catenin through its head domain, and
the expression of plakophilin 2 in SW480 cells up-regulates the
endogenous -catenin/T cell factor-signaling activity. This
up-regulation by plakophilin 2 is abolished by ectopic expression of
E-cadherin, suggesting that these proteins compete for the same pool of
signaling active -catenin. Our results demonstrate that plakophilin
2 interacts with a broader repertoire of desmosomal components than
plakophilin 1 and provide new insight into the possible roles of
plakophilin 2 in regulating the signaling activity of
-catenin.
 |
INTRODUCTION |
Plakophilins (PKPs)1
1-3 belong to a subfamily of p120-related armadillo proteins found in
both the desmosomal plaque and the nucleus (1-5). Each is composed of
a basic N-terminal head domain followed by a series of 10 imperfect
42-amino acid repeats (arm repeats) and a short C-terminal tail (3).
Two splice variants have been identified for PKP1 and PKP2, a shorter
"a" form and a longer "b" form. Although the N-terminal head
domains of PKPs exhibit relatively greater sequence diversity than the
arm-repeat domains, a consensus sequence termed HR2 is shared by all
the PKP head domains (3, 4). PKP1 is concentrated in desmosomes of the
suprabasal layers of stratified and complex epithelia (5). PKP3 can be
detected in desmosomes of most simple and almost all stratified
epithelia with the exception of hepatocytes and hepatocellular carcinoma cells (3, 4). PKP2 has the broadest tissue distribution in
desmosomes of all simple, complex, and stratified epithelia as well as
non-epithelial tissues such as myocardium and lymph node follicles, in
which PKP1 was not detected in desmosomes. PKP2 is concentrated in the
basal layer of most stratified squamous epithelia, whereas PKP1 is
mostly concentrated in desmosomes of the upper layers (2-4, 6). On the
other hand, PKP3 is more uniformly expressed in the living epidermal
layers (3, 4). PKPs have been detected in both desmosomes and nuclei in
desmosome-possessing cells and only in nuclei in desmosome-lacking
cells, but the mechanisms responsible for this dual location and their
functions in these two different environments are still poorly understood.
Members of the armadillo family, to which PKPs belong, play critical
structural and regulatory roles through their interactions with
proteins in two related intercellular adhesive junctions, desmosomes
and adherens junctions, which anchor intermediate filament (IF)
networks and actin filaments to sites of cell-cell contact (7-10). The
best characterized interactions of the desmosomal armadillo proteins
are those in which plakoglobin (Pg) participates. Pg associates
directly with the cytoplasmic domains of the desmosomal cadherins,
transmembrane glycoproteins of desmosomes that are further subdivided
into the desmoglein (Dsg) and desmocollin (Dsc) subfamilies. Three
isoforms exist for each of these subfamilies, which are expressed in a
cell type- and differentiation-dependent manner (8, 11,
12). Plakoglobin links desmosomal cadherins to IF through its
interactions with the plakin family member desmoplakin (DP).
Functionally, loss of Pg function through mutation or genetic ablation
leads to heart and skin defects, supporting the fact that this link
between the cadherins and the IF-desmoplakin complex plays a key role
in tissue integrity (13-15).
PKP1 also plays a critical role in tissue integrity, as patients null
for PKP1 show histological evidence of aberrant desmosomes and poorly
anchored IF and suffer from ectodermal dysplasia accompanied by skin
fragility (16). Whereas DP in normal epidermis is concentrated in
desmosomes, this plaque protein exhibits a largely diffuse, cytoplasmic
distribution in PKP1 null patients. This observation raises the
possibility that PKP1 is required for the efficient association of DP
with the junctional plaque. Subsequent studies provided evidence
supporting this hypothesis, showing that PKP1 can directly interact
with the DP N terminus and enhance its recruitment to the plasma
membrane. Furthermore, PKP1 collaborates with Pg and DP to promote the
clustering of desmosomal plaque complexes at cell-cell borders and to
enhance IF association with the plaque (17-19). Together, these
results have led to the proposal that PKP1 is important in
strengthening the desmosomal plaque by enhancing lateral
protein-protein interactions. However, virtually nothing is known about
the roles of other PKPs in desmosomes and how their participation in
desmosomes affects the specific organization or functions of desmosomes
in different tissues and stages of differentiation.
In addition to their function in intercellular junctions, some
armadillo family members also play roles in cellular activities outside
of the junctions. Both Pg (20) and p120 (21) have been found in the
nucleus and implicated in various signaling pathways (22-26); however,
the best-studied example is -catenin. This close relative of Pg
connects the cytoplasmic tails of classical cadherins with
actin-binding proteins such as -catenin to provide the linkage
between actin filaments and adherens junctions (27). Besides its
important roles in cell-cell adhesion, -catenin is a critical
downstream effector of the Wnt-signaling pathway, which mediates
a large variety of developmental processes (28, 29). The cellular level
of -catenin is tightly controlled by a complex of proteins that
facilitates its rapid degradation, whereas activation of the
Wnt-signaling pathway antagonizes the degradation process and leads to
the accumulation of free, cytoplasmic -catenin. -Catenin can then
translocate into the nucleus and activate target gene transcription in
association with TCF/Lef1 transcription factors (30). Since the
recognition of its role in Wnt signaling, an increasing number of
proteins have been discovered to interact with -catenin and regulate
its signaling activity through various mechanisms (31). PKPs, like
their armadillo family relatives, are also found in the nucleus. So far
evidence for participation of PKPs in -catenin-dependent
signaling has not been reported. A recent study showed that nuclear
PKP2 is complexed with the RNA polymerase III holoenzyme and interacts
directly with its largest subunit RPC155 in vitro,
opening up additional possibilities for the nuclear activity of PKP2
(32). However, because only a subset of PKP2 was observed in these
complexes, other nuclear functions for this arm-repeat subfamily of
proteins may exist.
PKP2 is the most ubiquitously expressed PKP family member, suggesting
that it has broad cellular functions. In this study, to elucidate the
biological functions of PKP2, we have characterized its protein
interactions with other junctional molecules. Here we show that PKP2
interacts directly with the obligate desmosome components Pg and DP as
well as the desmosomal cadherins Dsg1, Dsg2, Dsc1a, and Dsc2a and may
interact indirectly with Dsg3. PKP2 is less efficient than PKP1 in
enhancing the recruitment of excess DP to cell borders, which is
consistent with the weaker interaction observed between PKP2 and DP and
indicates distinct roles for these two PKPs in desmosome assembly. In
addition, PKP2 can associate with non-cadherin-bound -catenin and
regulate its signaling activity in TOPFLASH reporter assays. This novel
association with a component of adherens junctions and the
Wnt-signaling pathway raises the possibility that PKP2 might
participate in cross-talk between the two major types of intercellular
junctions and signal transduction pathways connecting the cell surface
and the nucleus.
 |
EXPERIMENTAL PROCEDURES |
Generation of cDNA Constructs--
To generate the probe
used for library screening, a partial PKP2 cDNA clone in pRSET-A
vector (p673) was digested with BamHI and NcoI to
isolate the insert nucleotides 1009-2401 of the PKP2 a splicing
variant (PKP2a) cDNA. Numbering of the PKP2a cDNA sequence is
based on the mRNA sequence for PKP2a and 2b (GenBankTM
accession number X97675) and the protein sequence of PKP2a (GenBankTM accession number CAA66265). This fragment
was used to screen a normal human keratinocyte ZAPII library
(provided by Dr. Masayuki Amagai). Clone (C1-1) containing PKP2a
nucleotides 1-1849 was digested with KpnI and
EcoRI to purify the fragment containing PKP2a nucleotides
1-1318, which was ligated into the EcoRI and
KpnI sites of pBS vector to generate plasmid p793 (nt 1-1318). p793 was digested with XbaI, end-filled, and then
digested with KpnI to cut out the insert, which was then
ligated into a 3.4-kb fragment of p673, which had been digested with
NcoI, end-filled, and digested with KpnI. The
resulting plasmid p792 contains PKP2a nucleotides 1-2401 in pBS. To
obtain the missing C terminus of PKP2a (nt 2402-2514), PCR was
performed using the total phage DNA isolated from the above library
with forward primer XC5' (5'-GGACCAATGCCAACATC-3') and reverse primer
XC3' (5'-GTCGACGTCTTTAAGGGAG-3'). The resulting PCR product, spanning
nucleotides 2008-2511 and containing an engineered SalI
site at the 3' end, was directly cloned into the pGEM-T vector
(Promega) to generate clone XC1-4. XC1-4 was double-digested with
MscI and SphI to isolate the C terminus of PKP2a,
which was then cloned into the 4.9-kb fragment of p792 digested with
MscI and SphI, thus creating the complete PKP2a
cDNA in pBS (p829). Complete sequencing of the PKP2a cDNA
revealed three nucleotide differences compared with the originally
published PKP2a sequence (2) (GenBankTM accession number
X97675). The first difference is a C to T transition at nt 1097 that
changes a Pro to Leu. Because this difference came from a phage clone
and was also found in multiple EST clones, it was considered as a
polymorphic difference in the PKP2a cDNA sequence. The other two
differences are a G to T change at nt 1886 and an A to G change at nt
2164, both of which were found in PCR-generated plasmid p673 and were
not present in any EST clones in the GenBankTM data base.
So they were interpreted as errors introduced by the cloning process
and corrected as described below.
A mammalian expression construct of PKP2a (p830) was constructed by
ligating an EcoRI-SalI fragment from p829 into
pFLAG-CMV-5 vector. The two random mutations at PKP2a cDNA sequence
1886 and nt 2164 were corrected using the QuikChange site-directed
mutagenesis kit (Stratagene), and the resulting plasmid (p915) was
fully sequenced to ensure that there were no additional mutations.
Construct p915 is the expression construct for PKP2a used in this
study. The N-terminal head domain of PKP2a (PKP2a-H) was generated by
PCR using primers PHN (5'-GATGAATTCCACGATGGCAGCCCCCG-3') and PHC
(5'-CATGTCGACGTCTGCATTCCCCAGC-3') with p915 as the template. The PCR
product contains an EcoRI site and a Kozak consensus
sequence at the 5' end and a SalI site at the 3' end. After
ligation of the PCR product into pGEM-T vector and subsequent digestion
with EcoRI and SalI, the PKP2a head domain (nt
1-1044) was ligated into pFLAG-CMV-5. The procedure of generating the
remaining portion of PKP2a (PKP2a-A) including the arm-repeat domain
and the C terminus into the pFLAG-CMV-5 vector was the same as above
except for the primers used in the PCR reaction. The forward primer
used was PAN (5'-GATGAATTCCACGATGGAGATGACTCTGGAG-3'), and the reverse
primer was PAC (5'-CATGTCGACGTCTTTAAGGGAGTGGTAGGC-3'). To generate the
full-length PKP1a with a FLAG-epitope tag at its C terminus, a
full-length a form of PKP1 in pCMV script vector p724 (19) was used as
the template for PCR using primers PKP1-nt-1745 (5'-CCTGCAATCTGGCAACTCTG-3') and PKP1.FLAG
(5'-CCTACTTGTCATCGTCGTCCTTGTAATCGAATCGGGAGGTGAAG-3'). The PCR
product that contains a FLAG epitope tag at its C terminus was
subsequently blunt end-ligated into pSK vector digested with EcoRV. This intermediate construct was diagnostically
digested to determine the orientation of the PCR insert and was
double-digested with BstEII and SalI to isolate
the PCR insert, which was then ligated into p724 digested with
BstEII and SalI to generate full-length FLAG-tagged PKP1a in pCMV script vector.
The HR2 domain of PKP2a contains amino acids 29-60. To generate the
expression construct of PKP2a with internal deletion of its HR2 domain
(PKP2a HR2), a SOEing (splicing by overlap
extension) procedure was utilized. PCR was performed with
p915 as the template using primer A (5'-GTATCATATGCCAAGTC-3') and
primer B (5'-GGCGAGGGTCTGCTGGGAGCTGTCCAGTTG-3') to obtain the PCR
product AB. A second PCR was performed with p915 as the template using
primer C (5'-CAGCAGACCCTCGCC-3') and primer D (5'-CTGCAGAAGCTTGAGG-3')
to obtain the PCR product CD. Then the final PCR was performed with a
mixture of product AB and CD as the template using primer A and primer
D to produce the PCR product AD. Product AD was digested with
NdeI and HindIII and cloned into the 5.6-kb
fragment from digesting p915 with NdeI and
HindIII, thus creating PKP2a HR2. It was then used as the template to generate the PKP2a head domain with HR2 deletion (PKP2a-H HR2) following the same procedure described above for generating PKP2a-H. To generate full-length DP with a C-terminal Myc tag, a
plasmid (p350) pCMV.DP.myc, which has a stop codon at nucleotide position 1754 due to mutation, was digested with DraIII and
SalI. The 7.5-kb fragment was ligated with the 5.1-kb
fragment from DraIII and SalI digestion of
plasmid p612, pSK.DP. C. This ligation generates full-length
DP in the pCMV vector with a C-terminal Myc tag (p613).
The following constructs were described previously: full-length human
Pg cDNA in a mammalian expression vector LK44 under the control of
the human -actin promoter (33); the Pg N and Pg C expression
constructs under the control of the -actin promoter (34); an
expression construct encoding a polypeptide comprising the first 584 amino acids of DP, called DPNTP (35). Full-length -catenin in
mammalian expression vector pCAN was provided by Dr. Paul Polakis.
Mammalian expression constructs of full-length human Dsg1 with a
C-terminal Myc tag and full-length human Dsg2 with a C-terminal Myc tag
were described previously (33, 36). The full-length human Dsg3 with
C-terminal Myc tag in the expression vector was a gift from Dr.
John Stanley.
Cell Culture and Transfections--
COS-7, HEK293, A431, and
HaCaT cells were cultured in Dulbecco's minimal essential medium with
penicillin/streptomycin and 10% fetal bovine serum. The SCC9 oral
squamous cell carcinoma cells were grown in Dulbecco's minimal
essential medium/F-12 medium with 10% fetal bovine serum and
penicillin/streptomycin. The SW480 human colon carcinoma cell line was
cultured in Leibovitz's L-15 medium supplemented with
penicillin/streptomycin and 10% fetal bovine serum. For transient
transfection of COS cells and HEK293 cells, calcium phosphate
transfection was performed as previously described (37), and
experiments were performed 42-46 h later. SCC9 and SW480 cells were
transfected using FuGENE 6 reagent (Roche Applied Science) according to
the manufacturer's protocol and assayed 24 h later.
Antibodies--
A rabbit polyclonal antibody poly-Myc 2026 directed against the c-Myc epitope and a rabbit polyclonal antibody
1880 against Dsg3 were kindly provided by Dr. John Stanley. A rabbit
polyclonal antibody against E-cadherin was a gift from Drs. Randy Marsh
and Robert Brackenbury. A mouse monoclonal antibody PC28 directed against the DP central rod domain was a gift from Dr. Pamela Cowin. A
monoclonal anti-c-Myc antibody 9E10 and rabbit polyclonal antibodies against -catenin (C2206) and -catenin (C2081) were purchased from
Sigma. A monoclonal anti- -catenin antibody C19220 was obtained from
Transduction Laboratories. A rabbit polyclonal antibody Oct-A probe
against the FLAG epitope was purchased from Santa Cruz Biotechnology,
Inc. The following antibodies were described previously: rabbit
polyclonal antibodies NW161 (35) and NW6 (38), directed against
desmoplakin; a chicken polyclonal antibody 1407 (39), directed against
plakoglobin; a mouse monoclonal antibody 6D8, directed against Dsg2
(35, 40).
Co-immunoprecipitation, Immunoblot, and Sequential Detergent
Extraction--
For co-immunoprecipitations, 100 or 60 mm dishes of
cells were washed in PBS, extracted in 1 ml or 500 µl of cold
co-immunoprecipitation buffer containing 1% Triton X-100, 145 mM NaCl, 10 mM Tris-HCl, pH 7.4, 5 mM EDTA, 2 mM EGTA, and 1 mM
phenylmethylsulfonyl fluoride. Lysates were then processed for
immunoprecipitation as described previously (41) using specific
antibodies. For immunoprecipitation of FLAG-tagged proteins,
anti-FLAG® M2-agarose affinity gel (Sigma) was used. Immunocomplexes
were separated on 7.5% polyacrylamide gels and electrophoretically
transferred to nitrocellulose, which was blocked with 5% dry milk in
PBS containing 0.1% Tween 20 and probed with appropriate primary and
secondary antibodies (Kirkegaard and Perry Laboratories) diluted in 5%
dry milk in PBS. Sequential detergent extraction was performed as
described (34) except that the amount of buffer used at each step was
adjusted so that the final volume of each pool was 400 µl.
Immunofluorescence--
Cells were plated on glass coverslips
the day before transfection in 6-well tissue culture dishes. 24 h
after transfection using FuGENE 6 reagent, cells were washed in PBS,
fixed in methanol for 2 min at 20 °C, and incubated with
appropriate antibodies diluted in complete PBS. Cells were incubated
with primary antibodies for 30 min at 37 °C, washed, and incubated
with secondary antibodies for 30 min at 37 °C. The following
antibodies were used at indicated dilutions: PC28 at 1:200, C2206 at
1:50, C19220 at 1:50, Oct-A-probe at 1:50, Alexa Fluor®-conjugated
goat anti-mouse or goat anti-rabbit secondary antibodies (Molecular
Probes, Eugene, OR) were used at 1:300. Images were obtained on a Leitz
DMR microscope using a Hamamatsu Orcal digital camera and Openlab
imaging software (Improvision).
Yeast Two-hybrid Constructs and Assays--
The plakoglobin
construct lacking the N-terminal domain (Pg N) in pACTII vector was
described previously (p515) (42). The cDNA sequence encoding Pg N
was removed from p515 by digestion with NcoI and
XhoI and subcloned into the same sites of pAS-CYH2 to create
Pg N in pAS-CYH2. Plasmid p525, which contains cDNA sequence of
DPNTP in pBluescript (42), was digested with BamHI and
SalI, and DPNTP was subcloned into the BamHI and
XhoI sites of pACTII vector (p900). The PKP1a head domain in
DNA binding domain vector pBD-GAL4 (Stratagene) was described
previously (19). The intracellular domains of Dsg1, Dsg2, Dsg3, Dsc1a,
and Dsc2a in pGAD424 vector were described previously (18). These
inserts were removed from the pGAD424 vector by digestion with
EcoRI and SalI and cloned into the
EcoRI and XhoI sites of pGADT7 vectors. The mouse
E-cadherin cytoplasmic domain comprises amino acids 741-884 and was
generated by PCR with primers containing EcoRI and
SalI sites and cloned into the EcoRI and
XhoI sites of pGADT7. Full-length human -catenin was
cloned into the SmaI and BamHI sites of pGAD424.
Both the human p120 catenin isoform 3AC and the cytoplasmic domain of
protocadherin 15 were cloned into the EcoRI and
SalI sites of pGBKT7. Full-length PKP2a, its head domain,
and the headless portion of PKP2a were amplified by PCR and cloned into
the SmaI site of pAS-CYH2 vector and confirmed by DNA sequencing.
To assay interactions between proteins, yeast strain Y189 or AH109 was
co-transformed with two testing plasmids, and dual transformants were
selected by growth on plates lacking both tryptophan and leucine.
Transformations were performed according to methods in the
MatchmakerTM two-hybrid product protocol
(CLONTECH Laboratories Inc.). Briefly, competent
yeast cells were transformed with 1-5 µg of each plasmid DNA using a
standard lithium acetate/polyethylene glycol method. For the Y189
strain, positive interactions were quantified by measuring the
-galactosidase activity using 4-mythylumbelliferyl -D-galactopyranoside as a substrate following the
methods described before (43). For AH109 strain, dual transformants
were tested for their ability to grow on SD-Leu-Trp-His-Ade
plates and their ability to turn blue in the presence of
X- -gal. Materials for base media and agar were purchased from Difco,
and materials for the defined media were purchased from
CLONTECH Laboratories Inc.
TOPFLASH Luciferase Assay--
TOPFLASH and FOPFLASH luciferase
reporter gene constructs were generously provided by Dr. Bert
Vogelstein. TOPFLASH reporter gene construct contains optimized
TCF-binding sites upstream of a luciferase reporter gene, whereas the
FOPFLASH contains mutated sites that do not bind TCF (44). SW480
cells were seeded at 2.75 × 105 cells/well in 6-well
dishes 24 h before transfection. Each well was transfected with
0.25 µg of either TOPFLASH or FOPFLASH, 0.05 µg of pRL-TK (Promega)
as an internal control for transfection efficiency, and 1 µg of each
indicated test construct. The total amount of DNA in each transfection
was kept constant by the addition of an empty expression vector plasmid
(pCMV-FLAG). Transfections were performed in triplicate using FuGENE 6 reagent (Roche Applied Science), and luciferase assays were performed
24 h later following the protocol provided for the
Dual-LuciferaseTM reporter assay system (Promega). Luciferase activity
was corrected for transfection efficiency by using the control pRL-TK
activity. Each experiment was performed at least three times independently.
 |
RESULTS |
The Head Domain of PKP2a Is Sufficient for Its Cell Border
Localization--
Because PKP1a associates with desmosomal components
and is targeted to desmosomes through its head domain (18), we tested whether the PKP2 head domain is similarly responsible for its localization to cell borders. PKP2a, PKP2a-H, or PKP2a-A (Fig. 1) were transiently transfected into the
SCC9 keratinocytes, and their subcellular distribution was examined
with respect to the endogenous desmosomal marker DP. Ectopic
full-length PKP2a was distributed primarily in a continuous fashion
along cell borders (Fig. 2a),
which overlapped, but was not completely coincident, with the punctate
discontinuous pattern exhibited by endogenous DP (Fig. 2b).
This distribution pattern of PKP2a suggests that overexpressed PKP2a
might be associated with non-desmosomal components at the plasma
membrane.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic diagram of plakophilin constructs
used in this study. The top two constructs are full-length PKP1a
and PKP2a. Deletion constructs of PKP2a were generated including the
PKP2a head domain (PKP2a-H), the PKP2a headless fragment
containing the arm-repeat domain and C-terminal tail
(PKP2a-A). The HR2 domain of PKP2a (amino acids 29-60) was
internally deleted to generate PKP2a with deletion of the HR2 domain
(PKP2a HR2) and PKP2a head domain with
deletion of HR2 domain (PKP2a-H
HR2). The numbers indicate amino acid
position, and the black box represents the HR2 domain. PKPs
have 10 arm-repeats, shown as open boxes. All the constructs
were C-terminally tagged with a FLAG epitope (star).
|
|

View larger version (79K):
[in this window]
[in a new window]
|
Fig. 2.
The head domain of PKP2a is
sufficient for its border localization. SCC9 cells, which assemble
numerous desmosomes, were transiently transfected with PKP2a
(a and b), the deletion constructs PKP2a-H
(c and d), or PKP2a-A (e and
f). 24 h after transfection, cells were processed for
double-label immunofluorescence using the polyclonal antibody
Oct-A-probe to detect the FLAG epitope of ectopic polypeptides
(a, c, and e) and the monoclonal
antibody PC28 to detect endogenous DP (b, d, and
f). Both PKP2a and its head domain are distributed in the
cytoplasm and along cell borders, where they partially colocalize with
endogenous DP (a-d). PKP2a-A is diffuse throughout the
cytoplasm without specific border localization (e). PKP2a
head domain is often found to concentrate in the nucleus
(c). Scale bar, 10 µm.
|
|
The head domain of PKP2a (PKP2a-H) colocalized more extensively with
endogenous DP and appeared more punctate compared with full-length
PKP2a (Fig. 2c). In addition, the PKP2a head domain was
detected in the cytoplasm as discrete dots. In contrast to full-length
ectopic PKP2a, which was rarely seen concentrated in the nucleus, in
about 50% of the transfected cells the PKP2a head domain was detected
in the nucleus. The PKP2a head domain was also localized to both cell
borders and the nucleus in Madin-Darby canine kidney, HeLa, and COS
cells (data not shown), reminiscent of the intracellular localization
reported for the PKP1a head domain (17, 18). In contrast, PKP2a-A
exhibited a largely diffuse distribution throughout the cytoplasm
without any specific pattern or cell border localization. Cells
overexpressing PKP2a-A were also frequently found to form many
filopodia-like membrane protrusions and to have altered morphology.
These results suggest that the PKP2a head domain, which also has the
ability to accumulate in the nucleus, is sufficient for the membrane
targeting of PKP2a.
PKP2a Co-immunoprecipitates with DP and the N-terminal 584 Amino
Acids Polypeptide DPNTP--
It was shown previously that PKP1a
interacts directly with the N-terminal domain of DP and enhances the
recruitment of ectopic and endogenous DP to cell-cell borders (18, 19).
To compare the ability of PKP2a and PKP1a to interact with DP,
full-length DP or DPNTP was transiently expressed in HEK293 cells with
or without one of the PKP constructs, followed by immunoprecipitation using M2-agarose to precipitate FLAG-tagged PKP1a or PKP2a and the
associated proteins. As shown in Fig. 3,
like PKP1a, PKP2a co-immunoprecipitated DP and DPNTP. Neither DP nor
DPNTP was nonspecifically detected in the immunocomplexes with
M2-agarose when expressed alone. Although similar amounts of PKP1a and
PKP2a were immunoprecipitated by M2-agarose, substantially more
full-length DP or DPNTP was present in the immunocomplex with PKP1a,
suggesting that DP may interact more robustly with PKP1a than with
PKP2a. This possible difference in the strength of the interactions
between DP and two plakophilins was further supported by yeast
two-hybrid results (Fig. 6).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 3.
PKP2a co-immunoprecipitates both full-length
DP and its N-terminal polypeptide DPNTP. DP or DPNTP was
transiently expressed in HEK293 cells either alone or together with
FLAG-tagged PKPs, which were then immunoprecipitated by M2-agarose,
which binds the FLAG epitope of ectopic PKPs. The cell lysates and
immunocomplexes were analyzed by Western blot to detect DP and DPNTP
using the anti-DP antibody NW161 and to detect ectopic PKPs using the
anti-FLAG antibody Oct-A-probe. Both PKP1a and PKP2a specifically
co-precipitate DP and DPNTP, but more DP and DPNTP are found to be
co-immunoprecipitated by PKP1a than by PKP2a. The variable levels of DP
and DPNTP observed in cell lysates are likely due to promoter
competition that results from transfection of multiple plasmids.
|
|
PKP2a Co-immunoprecipitates Pg and the Arm-repeat
Domain of Pg Is Sufficient for This Association--
In a previous
study, it was reported that PKP1a was unable to interact with Pg in an
in vitro overlay assay (45). Here, the ability of PKP1 and
PKP2 to interact with Pg was compared by co-immunoprecipitation from
transiently transfected COS cells. In agreement with previous findings,
we detected little or no Pg association with PKP1a (Fig.
4A). In contrast, when Pg was co-expressed with FLAG-tagged PKP2a in COS cells followed by
immunoprecipitation using M2-agarose, Pg was efficiently
co-precipitated together with PKP2a (Fig. 4B). Deletion of
either the N-terminal head or C-terminal tail of Pg did not adversely
affect its association with PKP2a, indicating that the Pg arm-repeat
domain primarily mediates the interaction. A similar amount of PKP2a
co-immunoprecipitated considerably more Pg C than either Pg N or
full-length Pg. Next, the ability of the PKP2a head domain (PKP2a-H)
and PKP2a arm-repeats with the C-terminal tail (PKP2a-A) to
co-immunoprecipitate Pg was tested (Fig. 4C). PKP2a-H
co-precipitated less Pg compared with full-length PKP2a, and PKP2a-A
was even less efficient in doing so, considering the much higher amount
of PKP2a-A present in the cell lysates and the immunocomplex.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 4.
PKP2a co-immunoprecipitates Pg and its
terminal deletion mutants. A, PKP1a is unable to
co-immunoprecipitate Pg efficiently. Pg was expressed either alone or
together with FLAG-tagged PKP1a followed by immunoprecipitation with
M2-agarose and Western blot analysis with 1407 and Oct-A-probe.
B, terminal domains of Pg are not essential for its
association with PKP2a. Pg and its deletion mutants were transiently
expressed in COS cells either alone or together with FLAG-tagged PKP2a
followed by immunoprecipitation with M2-agarose and Western blot
analysis. An anti-Pg polyclonal antibody 1407 was used to detect Pg,
and anti-FLAG antibody Oct-A-probe was used to detect FLAG-tagged
PKP2a. PKP2a co-immunoprecipitates Pg and its deletion mutants lacking
either the N-terminal or C-terminal domain. C, deletion of
the head or arm-repeat domain of PKP2a abrogates its association with
Pg. Pg was transfected either alone or together with different
FLAG-tagged PKP2a constructs followed by immunoprecipitation with
M2-agarose and Western blot analysis. The ability of PKP2a to
co-precipitate Pg is severely compromised by the deletion of PKP2a
arm-repeat domain plus C-terminal tail and almost completely abolished
by the deletion of PKP2a head domain.
|
|
PKP2a Co-immunoprecipitates Dsg1 and Dsg2 but Not Dsg3 When
Co-expressed in COS Cells, and the HR2 Domain of PKP2a Is Not Necessary
for Its Complex Formation with Other Desmosomal Components--
To
investigate possible interactions between PKP2a and the three
desmoglein isoforms Dsg1, -2, and -3, co-immunoprecipitation experiments were performed using lysates from transiently transfected COS cells. PKP2a specifically co-immunoprecipitated both Dsg1 and Dsg2
but not Dsg3 (Fig. 5A). The
PKP2a head domain, but not its arm-repeat domain, mediated the
interaction between PKP2a and Dsg2 (data not shown). The parallel
experiment could not be successfully performed with Dsg1 due to
quenched expression of the Dsg1 construct when co-transfected with
PKP2a-H. Because COS cells express endogenous Pg, which might be able
to interact with both PKP2a and Dsg1 or Dsg2 in the same complex, we
attempted to determine if the association of Dsg2 with PKP2a was
mediated by a limiting amount of free endogenous Pg. If this were the
case, it should be possible to elevate the amount of Dsg2 associated with PKP2a by co-expression of ectopic Pg. However, the presence of
ectopic Pg did not influence the level of Dsg2 co-precipitated with
PKP2a (Fig. 5B).

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 5.
PKP2a co-immunoprecipitates Dsg1, Dsg2 but
not Dsg3 from co-transfected COS cells, and endogenous Pg and Dsg3 from
singly transfected SCC9 cells. A, each of the three Dsg
isoforms was transiently expressed in COS cells either alone or
together with FLAG-tagged PKP2a followed by immunoprecipitation with
M2-agarose and Western blot analysis of the immunocomplex and cell
lysates. Dsg1 was detected with the poly-Myc antibody, Dsg2 was
detected with the anti-Dsg2 antibody 6D8, and the anti-Dsg3 antibody
1880 was used to detect Dsg3. B, co-expression of Pg does
not enhance the association between PKP2a and Dsg2. Dsg2, Pg, and
FLAG-tagged PKP2a were transiently expressed in COS cells in
combinations as indicated followed by immunoprecipitation with
M2-agarose and Western blot analysis. The poly-Myc antibody was used to
detect the Myc-tagged ectopic Pg. C, the HR2 domain of PKP2a
is not required for its association with other desmosomal components.
Different desmosomal molecules (DM) were transiently
expressed in HEK293 cells either alone or together with PKP2a or
PKP2a HR2, both of which are FLAG-tagged and were immunoprecipitated
with M2-agarose. Deletion of the HR2 domain in PKP2a does not affect
its co-immunoprecipitation with other desmosomal components.
D, SCC9 cells were transiently transfected with either empty
vector or FLAG-tagged PKP2a construct, and the Triton-soluble cell
lysates were subjected to co-immunoprecipitation using M2-agarose
to isolate ectopic PKP2a and its associated endogenous proteins. Pg,
Dsg3 but not Dsg2 were detected in the complexes with ectopic
PKP2a.
|
|
The conserved HR2 domains in the head domains of PKPs have been
postulated to be important for certain common functions (3, 4).
However, deletion of HR2 from PKP2a did not affect its ability to
co-immunoprecipitate other desmosomal components (Fig. 5C).
In addition, both PKP2a HR2 and PKP2a-H HR2 exhibited the same
distribution pattern as their respective wild-type counterparts PKP2a
and PKP2a-H when expressed in SCC9 cells (data not shown). These
results suggest that the HR2 domain of PKP2a is not critical for either
its association with other desmosomal components or its proper
localization in cells.
Association of Ectopic PKP2a with Endogenous Desmosomal
Components--
To determine whether PKP2a exhibits the same
repertoire of interactions with endogenous desmosomal proteins, we
analyzed endogenous desmosomal proteins that co-precipitated with
FLAG-tagged PKP2a in SCC9 epithelial cells. When transiently expressed
FLAG-tagged PKP2a was immunoprecipitated from the 1% Triton
X-100-soluble cell lysates of SCC9 cells, endogenous Pg was
consistently detected in the immunocomplex (Fig. 5D). DP,
which is mostly insoluble, was variably detected in the complex with
PKP2a (not shown), suggesting a weak and/or transient association.
Surprisingly, whereas Dsg3 was present at low levels in the
immunocomplex with ectopic PKP2a, we could not detect endogenous Dsg2
co-precipitated by ectopic PKP2a from SCC9 cells.
Yeast Two-hybrid Analysis of Protein Interactions between PKP2a and
Other Desmosome Components--
To extend the results obtained using
co-immunoprecipitation assays, the ability of PKP2a to interact
directly with DPNTP, Pg N, and the desmosomal cadherin tails was
tested using the yeast two-hybrid system. The relative strength of
interactions between DPNTP and PKP1a or PKP2a was compared using yeast
strain Y187 because it is more suitable for quantitative
-galactosidase assays. Consistent with previous reports (19), DPNTP
interacted strongly with the head domain of PKP1a (Fig.
6). DPNTP directly interacted with
full-length PKP2a and its head domain at a much weaker level but not
with the arm-repeat domain of PKP2a. PKP2a and its head domain, but not
PKP2a-A, interacted directly with Pg N at a similar level.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 6.
PKP2a interacts directly with DPNTP and
Pg N in yeast two-hybrid assays. Yeast
strain Y187 cells were co-transformed with DPNTP or Pg N in pACTII
vector and various PKP constructs as indicated. Co-transformants were
selected on plates lacking tryptophan and leucine ( Trp/ Leu), and
individual clones were used for quantitative -galactosidase assay.
Each bar represents the average of triplicate measurements
for an independent clone. Interaction between p53 and large T antigen
(LgT) is shown as a positive control. The measurements for
the interactions between PKP2a-A and either DPNTP or Pg N are
negligible. DPNTP interacts most strongly with PKP1a head domain
and at a much weaker level with both PKP2a and its head domain. Pg N
directly interacts with PKP2a and its head domain but not with PKP2a-A.
No significant measurements were obtained from clones co-transformed
with PKP constructs and pACTII empty vector (data not shown). MUG,
4-mythylumbelliferyl
-D-galactopyranoside.
|
|
Yeast two-hybrid assays employing growth and blue/white selection
demonstrated that PKP2a directly interacted with the cytoplasmic domains of Dsg1, Dsc1a, and Dsc2a but not with Dsg2 or Dsg3 (Table I). The PKP2a head domain interacted with
both Dsg1 and Dsg2 directly. However, no interactions were detected
between PKP2a-A and any of the cytoplasmic domains, nor was an
interaction detected between PKP2a and E-cadherin. As a positive
control, the E-cadherin cytoplasmic domain interacted with p120 catenin
in the same assay (data not shown).
View this table:
[in this window]
[in a new window]
|
Table I
Yeast two-hybrid analysis of protein-protein interactions
AH109 yeast cells were co-transformed with PKP2a or its subdomains in
pAS-CYH2 and with the cytoplasmic domains (cyto) of desmosomal
cadherins in pGADT7, full-length -catenin in pGAD424 ( -cat), or
the cytoplasmic domain of E-cadherin in pGADT7 (E-cad cyto). Positive
interactions were determined through analyzing the abilities of
co-transformants to grow and turn blue on selection plates lacking
adenine, histidine, leucine and tryptophan and containing X- -gal.
Three separate clones from each co-transformation were assessed, and
the same results were obtained for all three clones in all the assays.
Clones that could grow as blue colonies on selection plates were
considered as positive and are designated with plus symbols, and clones
that did not show growth on the selection plates were considered as
negative and are designated with minus symbols. White colonies were not
observed. ND, not determined.
|
|
PKP1a and PKP2a Exhibit Different Localization Patterns and
Abilities to Enhance the Border Recruitment of Excess DP When
Overexpressed in COS Cells--
The protein interaction studies
described above suggest that PKP1a and PKP2a have overlapping but
distinct repertoires of desmosomal binding partners and that they may
contribute differently to desmosome assembly. It has been suggested
that a critical function of PKP1 is its ability to enhance DP
recruitment to desmosomes (19). Therefore we compared the abilities of
PKP1a and PKP2a to recruit DP to cell-cell borders in transiently
transfected COS cells. As reported previously (17), PKP1a localized to
both the nucleus and cell borders in COS cells when it was expressed alone (Fig. 7A,
a'), and its expression resulted in increased border
staining for endogenous DP compared with adjacent, non-transfected cells (Fig. 7A, a, arrow). Staining
for endogenous DP in the population of non-transfected cells is weak to
undetectable (Fig. 7A, a and b,
arrowhead). In contrast to the intense nuclear accumulation of PKP1a observed in more than 95% of transfected COS cells, less than
10% of cells transfected with PKP2a showed weak nuclear staining. Like
PKP1a, PKP2a enhanced the recruitment of endogenous DP to cell borders
(Fig. 7A, b and b').

View larger version (87K):
[in this window]
[in a new window]
|
Fig. 7.
Subcellular localization of PKP1a
and PKP2a in COS cells and their abilities to enhance the cell border
recruitment of DP. A, localization of overexpressed
PKP1a and PKP2a and their effects on the distribution of endogenous DP
in COS cells. COS cells were transiently transfected with either
FLAG-tagged PKP1a (a and a') or FLAG-tagged PKP2a
(b and b'). Double-label immunofluorescence was
carried out to detect the localization of ectopic PKPs using the
anti-FLAG antibody Oct-A-probe (a' and b') and
the localization of endogenous DP using the anti-DP antibody PC28
(a and b). Both PKP1a and PKP2a are localized to
cell borders, where they colocalize with and enhance the staining of
endogenous DP. PKP1a is also found intensely in the nucleus
(a'). The arrows (a and b)
indicate enhanced border staining of endogenous DP. The
arrowheads (a and b) point to cell
borders between untransfected cells. B, COS cells were
co-transfected with DP together with FLAG-tagged PKP2a (a,
b, a', and b') or FLAG-tagged PKP1a
(c and c') followed by double-label
immunofluorescence using antibodies against the FLAG epitope
(a', b', and c') and DP
(a-c). Ectopic PKP2a colocalizes extensively with
overexpressed DP along intermediate filaments and cell borders
(a, b, a', and b').
Overexpression of DP alone in COS cells results in its colocalization
mainly along intermediate filaments (a, inset).
Ectopic PKP1a is localized predominantly to the nucleus and along cell
borders, where DP is strongly recruited. The IF pattern of distribution
of overexpressed DP is dramatically reduced when PKP1a is co-expressed
(c and c'). Scale bars, 10 µm.
|
|
Interestingly, the difference between PKP1a and PKP2a in their ability
to enhance DP recruitment was revealed when both PKP and DP were
co-transfected into COS cells. When expressed alone, ectopic DP
predominantly colocalized with the IF network in the cytoplasm and
sometimes localized to cell borders in transfected COS cells as
described before (Fig. 7B, a, inset)
(17). When PKP2a was co-expressed with DP, both PKP2a and DP
colocalized extensively along intermediate filaments (Fig.
7B, a and a') and could also be
detected along cell borders in certain cases (Fig. 7B,
b and b'). In comparison, co-expression of PKP1a
and DP resulted in a dramatic recruitment of DP to cell-cell borders
together with PKP1a and a concomitant disappearance of DP from IF
networks in co-transfected cells (Fig. 7B, c and
c'). Co-expression with DP did not affect the accumulation
of PKP1a in the nucleus (Fig. 7B, c'). These
results showed that even though both PKPs can enhance the recruitment
of endogenous DP to cell borders, PKP1a is much more efficient than
PKP2a in promoting the border localization of excess DP.
PKP2a Co-immunoprecipitates the Adherens Junction Component
-Catenin, Which Forms Mutually Exclusive Complexes with either
E-cadherin or PKP2a--
In contrast to plakoglobin, which can be
found in both desmosomes and adherens junctions, -catenin is found
exclusively in adherens junctions through its direct interaction with
classical cadherins such as E-cadherin. Because PKP2a interacts with
the arm-repeat domain of plakoglobin, which is highly homologous to that of -catenin, we tested whether -catenin also binds to PKP2a. In co-immunoprecipitation experiments performed from transiently co-transfected COS cells, -catenin specifically co-precipitated with
both full-length PKP2a and its head domain but only very weakly with
PKP2a-A, suggesting that the head domain of PKP2a is mainly responsible
for its interaction with -catenin (Fig. 8A). Full-length PKP2a did not
co-precipitate two other adherens junction components -catenin and
E-cadherin in co-transfected COS cells, showing the specificity of its
association with -catenin in this assay (data not shown).
Full-length PKP2a interacted with -catenin in yeast two-hybrid
assays (Table I), suggesting that they directly bind to each other. The
negative control interaction between -catenin and protocadherin 15 was negative (data not shown).

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 8.
PKP2a associates with
-catenin that is not bound to E-cadherin.
A, the head domain of PKP2a is required for its association
with -catenin (cat). -Catenin was transiently
transfected into COS cells either alone or with different FLAG-tagged
PKP2a constructs as indicated, which were then immunoprecipitated with
M2-agarose. Western blots of cell lysates and immunocomplexes were
performed using the polyclonal anti- -catenin antibody C2206 and
anti-FLAG antibody Oct-A-probe. PKP2a and its head domain efficiently
co-immunoprecipitate -catenin, whereas the headless fragment PKP2a-A
almost completely loses this ability. B, PKP2a forms
complexes with -catenin that is not bound to E-cadherin.
-Catenin, E-cadherin, and FLAG-tagged PKP2a were co-expressed in COS
cells. Specific antibodies against -catenin (C19220) and the FLAG
epitope (M2) were used to immunoprecipitate -catenin and PKP2a,
respectively. -Catenin co-immunoprecipitates both PKP2a and
E-cadherin, but E-cadherin is not detected in the immunocomplex
associated with PKP2a, indicating distinct pools of -catenin in
association with either PKP2a or E-cadherin but not both of them. The
upper two bands recognized by the anti-E-cadherin antibody represent
the precursor and mature form, and the lower band is likely a breakdown
product lacking part of the cytoplasmic -catenin binding domain.
C, SCC9 cells were transiently transfected with either empty
vector or FLAG-tagged PKP2a construct and the Triton-soluble cell
lysates were subjected to co-immunoprecipitation using M2-agarose to
isolate ectopic PKP2a and its associated endogenous proteins.
E-cadherin and -catenin but not -catenin were detected in the
complexes with ectopic PKP2a.
|
|
To determine if -catenin forms distinct complexes with PKP2a and
E-cadherin, COS cells were co-transfected with constructs expressing
E-cadherin, -catenin, and PKP2a. After immunoprecipitation of either
-catenin or PKP2a, the immunocomplex was analyzed for the presence
of E-cadherin. As shown in Fig. 8B, E-cadherin efficiently associated with -catenin when -catenin was immunoprecipitated with an anti- -catenin antibody; however, E-cadherin was not detected in the complex with PKP2a and -catenin when PKP2a was
immunoprecipitated by M2-agarose beads. This observation suggests that
the pool of -catenin associated with PKP2a is unable to interact
with E-cadherin and that -catenin forms mutually exclusive complexes
with E-cadherin and PKP2a.
To examine the complex formation between PKP2a and other adherens
junction components in a more physiological environment in
keratinocytes, SCC9 cells transfected with only FLAG-tagged PKP2a were
used for M2-agarose immunoprecipitation experiments. Both endogenous
E-cadherin and -catenin, but not -catenin, co-immunoprecipitated with PKP2a (Fig. 8C). The ability of ectopic PKP2a to
associate with endogenous -catenin is consistent with the protein
interaction data. The presence of endogenous E-cadherin in a complex
with ectopic PKP2a raises the possibility that in certain cell types, PKP2a might associate indirectly with E-cadherin through other protein
partners such as Pg. Indeed, when Pg was overexpressed in COS cells
with ectopic E-cadherin and PKP2a, a complex containing all three
proteins could be detected (not shown), which is in contrast to the
co-immunoprecipitation experiment described above for -catenin (Fig.
8B).
Because endogenous PKP2a and -catenin are localized to different
junctional complexes and do not usually colocalize with each other at
cell borders (Ref. 2; data not shown), we sought to determine whether
overexpressed PKP2a could colocalize with endogenous -catenin at the
membrane. Both PKP2a and its head domain colocalized with endogenous
-catenin at cell borders in transiently transfected SCC9 cells (Fig.
9). The expression of PKP2a or PKP2a-H
did not alter the distribution of endogenous -catenin or affect its
accumulation along cell borders. These data are consistent with PKP2a
having the ability to associate with -catenin in cells.

View larger version (79K):
[in this window]
[in a new window]
|
Fig. 9.
PKP2a and its head domain colocalize with
-catenin (cat) at the cell membrane. SCC9
cells were transiently transfected with FLAG-tagged PKP2a
(a, b, and c) or its head domain
PKP2a-H (d, e, and f), and
double-label immunofluorescence was carried out to detect endogenous
-catenin (b and e) and FLAG-tagged ectopic
proteins (a and d). Composite pictures are shown
to demonstrate the colocalization of -catenin with PKP2a and PKP2a-H
along the cell borders, as indicated in yellow (c
and f). Some of the overlapped signals do not appear
as yellow after the overlay because the intensity of the individual
signals is unequal.
|
|
The Effects of PKP2a on -Catenin/TCF Signaling--
Free,
cytoplasmic -catenin that is not bound to cadherins can participate
in the Wnt-signaling pathway through its interaction with TCF/Lef1
transcription factors (28). PKP2a co-precipitates with a
non-cadherin-bound pool of -catenin, raising the possibility that
PKP2a might be involved in regulating -catenin/TCF signaling. To
better understand the physiological consequence of the
PKP2a/ -catenin interaction, we investigated the effect of PKP2a on
-catenin/TCF-regulated transcription in human colon carcinoma line
SW480 cells, which have been shown to have constitutive -catenin/TCF
transcription activity (44, 46). TOPFLASH luciferase assays were
performed to measure the activation of -catenin/TCF signaling.
24 h after transfection, TOPFLASH reporter was strongly activated
by endogenous -catenin/TCF signaling in SW480 cells compared with
negligible FOPFLASH activity (0.012 ± 0.002) (Fig.
10). Overexpression of PKP2a
significantly elevated the activation of the TOPFLASH reporter by ~ 33% compared with vector control, and the FOPFLASH activity was
not significantly affected (0.011 ± 0.001). The level of
-catenin in the cell lysates was not affected by expression of
PKP2a. Double-label immunofluorescence showed that overexpressed PKP2a
was largely diffuse in the cytoplasm and excluded from the nucleus, and
no changes in the subcellular localization of -catenin were detected (data not shown). E-cadherin expression dramatically reduced the TOPFLASH activity as has been reported previously (47, 48). This
inhibition of -catenin/TCF signaling by E-cadherin requires its
-catenin binding site and was shown to involve the binding and
sequestering of -catenin from the signaling pool by E-cadherin (48).
Co-expression of E-cadherin with PKP2a in SW480 cells resulted in a
similar level of inhibition of TOPFLASH activity as by E-cadherin
alone. This inability of PKP2a to up-regulate TOPFLASH activity in the
presence of E-cadherin suggests that PKP2a may exert its effect on
-catenin/TCF signaling through interaction with the same pool of
signaling active -catenin that E-cadherin sequesters.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 10.
Effect of PKP2a on
-catenin/TCF signaling in SW480 cells. SW480
cells were transiently transfected with TOPFLASH luciferase reporter
gene and a control luciferase reporter gene pRL-TK to control for
transfection efficiency. The results are expressed as relative
activity, which is derived from dividing the TOPFLASH luciferase
activity by the activity of pRL-TK. The results are the means and S.D.
of triplicate values obtained in one representative experiment of
three. Negligible activity was observed using FOPFLASH reporter gene,
which contains mutated TCF-binding sites (data not shown). PKP2a
expression significantly elevated the TOPFLASH activity by ~33%
(p = 0.011), whereas E-cadherin expression inhibited
its activity and prevented its up-regulation by PKP2a. Mean relative
activities were not significantly different between cells expressing
E-cadherin and cells expressing both E-cadherin and PKP2a
(p = 0.405 > 0.05). Cell lysates prepared for the
reporter gene assay were quantitated, and the same amount of total
protein was analyzed by SDS-PAGE and Western blot using the
anti- -catenin (cat) antibody C2206. The total level of
-catenin is not altered by the expression of either PKP2a or
E-cadherin. The asterisk designates values significantly
different from control by Student t test at
p < 0.05.
|
|
 |
DISCUSSION |
PKPs represent a family of arm-repeat proteins present in both
desmosomes and the nucleus. Commonly found in stratified and complex
epithelia, PKPs exhibit cell type- and
differentiation-dependent patterns of desmosomal localization,
suggesting distinct roles in the regulation and function of desmosomes.
Their constitutive nuclear localization independent of their presence
in desmosomes points to possible novel functions in the nucleus. The
identification of human patients bearing PKP1 gene mutations has
provided compelling evidence for its critical involvement in organizing
and stabilizing desmosomes and further catalyzed the study on its role
in desmosomes. However, little is known about the function of its most
widely expressed relative, PKP2. In the present study, we investigated the ability of PKP2a to interact with other junctional molecules and
conducted functional analyses on its role in desmosome formation and
regulation of -catenin-signaling activity.
PKP1a has been shown to interact directly with DP, Dsg1, and keratin
(18, 45, 49) through its head domain (18, 19). We showed here by
co-immunoprecipitation from co-transfected cells that PKP2a associates
with DP, Pg, Dsg1, and Dsg2. Yeast two-hybrid analysis demonstrated
furthermore that interactions with DP, Pg, Dsg1, and possibly Dsg2 are
direct and further uncovered Dsc1a and 2a as PKP2a interaction
partners. Pg co-precipitated with PKP2a and the deletion of either the
N-terminal head or C-terminal tail of Pg failed to abrogate this
interaction, suggesting that it is primarily mediated by the arm-repeat
domain of Pg. Intriguingly, the association between Pg and PKP2a was
further enhanced by deletion of the Pg C-terminal end domain. Previous
work showed that Pg C expression in A431 cells caused formation of
longer desmosomes or groups of tandemly linked desmosomes that were
still attached to keratin intermediate filaments (34). It was proposed
that deletion of the Pg C terminus might enhance interactions with other desmosomal components and lead to generation of longer
desmosomes. Together with our data, it thus seems possible that
enhanced interaction between Pg C and PKP2a could contribute to the
effect on desmosome morphology previously attributed to Pg C expression.
PKP2a co-immunoprecipitated Dsg1 and Dsg2, but not Dsg3 in
co-transfected COS cells, and its interaction with Dsg1 was confirmed by yeast two-hybrid assays as being directly mediated by the PKP2a head
domain. It is unclear why we detected a direct interaction between the
Dsg2 cytoplasmic domain and the PKP2a head domain but not full-length
PKP2a in yeast two-hybrid assays, but it seems likely that a direct
binding site for Dsg2 is contained in the head domain of PKP2a in light
of the abilities of both PKP2a and PKP2a-H to co-precipitate Dsg2 in
transfected cells. The fact that increasing the level of cellular Pg
does not enhance the association between PKP2a and Dsg2 (Fig.
5B) is consistent with the hypothesis that Pg does not
interact with PKP2a and Dsg2 simultaneously. The binding sites in Pg
for Dsg1 and Dsc1a reside in its arm-repeat domain (40, 50, 51), as
does the binding site for PKP2a as we show here. Thus, it is possible
that desmosomal cadherins and PKP2a compete with each other for binding
to Pg. How the observed direct interactions discussed here translate
into the formation of the physiological complexes in cells may depend
on other factors, including the availability of specific protein
partners in specific cell types. For instance, although direct
interactions with Dsg3 were not observed in co-transfection or yeast
two-hybrid assays, Dsg3 was present in an endogenous complex with
ectopic PKP2, whereas Dsg2 was not (Fig. 5D). Together these
data suggest that Pg or other unknown proteins may mediate an indirect
association between PKP2a and Dsg3 but not Dsg2. The absence of an
identifiable complex between ectopic PKP2a and endogenous Dsg2 by
co-immunoprecipitation may also indicate that in SCC9 cells, which
express both Dsg3 and Dsg2, Dsg3 may compete more effectively for PKP2
due to its relative abundance compared with Dsg2 in the
detergent-soluble pool or other factors favoring this interaction.
The presence of PKP2 in desmosomes is widespread as it is found in all
simple epithelia and in complex epithelia where it is localized
throughout the layers and concentrated in desmosomes of the basal
layer. These localization data are consistent with our observations,
and together they suggest that PKP2a can associate with all Dsg
isoforms, either directly or indirectly. Thus PKP2 may be involved in
desmosome function on a much broader scale than PKP1, and it is
intriguing to consider that it may serve different functions when it is
associated with different desmosomal cadherins.
In COS cells, ectopic PKP1a efficiently enhances the recruitment of
DPNTP to cell borders, and this ability is conferred by the PKP1a head
domain (19). Because DPNTP contains only the first 584 amino acids of
DP and does not bind to IF, we compared the ability of PKP1a and PKP2a
to enhance the cell border recruitment of full-length DP that is
sequestered along the IF network. Co-expression of PKP1a with DP in COS
cells resulted in a pattern of DP distribution vastly different from
that when DP was expressed alone. Instead of exhibiting extensive
co-alignment with the IF network and occasional border localization, DP
was mostly concentrated along the borders, colocalizing with PKP1a. In
contrast, the majority of DP remained sequestered along IF in cells
co-expressing PKP2a and DP. The fact that both PKPs enhanced the border
localization of endogenous DP to a similar level (Fig. 7A,
a and b) could be due to a limiting amount of
endogenous DP available for recruitment and that to reveal the higher
capacity of PKP1a to recruit DP requires that excess DP be expressed.
The different abilities of PKP1 and PKP2 to enhance cell border
recruitment of ectopic DP in COS cells might be explained by several
mechanisms. Biochemical evidence suggested that DP interacts with PKP2a
less robustly than with PKP1a, and an interaction with a certain
strength could be required to directly recruit DP to cell borders by
PKPs. Secondly, the two PKPs might enhance DP recruitment indirectly
through their differential ability to recruit other desmosomal
components or as yet unidentified proteins. Furthermore, PKP2a could
differ from PKP1a in its propensity to incorporate into desmosomes, and
PKP1a may preferentially assemble into desmosomes in COS cells. Because
PKP2 has been found mostly concentrated in desmosomes in the basal
layer of various stratified epithelial tissues (2), perhaps the
participation of PKP2 in desmosomes of the basal layer contributes to
the formation of smaller (52) and possibly more dynamic desmosomes that
are suitable for the amplification and generation of new cells from the
basal layer. This may partly be achieved through the reduced capacity of PKP2 to recruit and stabilize other desmosomal components such as
DP.
Another striking difference between PKP1a and PKP2a is their ability to
accumulate in the nucleus in cells overexpressing these proteins. PKP1a
and its head domain efficiently concentrated in the nuclei when
expressed in a variety of cell lines (17-19). Here we show that PKP2a
is mostly excluded from the nucleus in transiently overexpressing
cells. The PKP2a head domain can localize to the nucleus more
efficiently than full-length PKP2a, indicating that the arm-repeat
domain of PKP2a either contains nuclear export signals or has the
ability to retain PKP2a in the cytoplasm through interactions with
other proteins.
Besides interacting with other desmosome plaque proteins, PKP2a is also
capable of associating with -catenin mainly through the PKP2a head
domain. Co-expression of E-cadherin, -catenin, and PKP2a led to the
formation of mutually exclusive complexes that contained -catenin
with either E-cadherin or PKP2a, suggesting that PKP2a is unlikely to
interact with -catenin in the adherens junction. However, ectopic
PKP2a formed complexes with endogenous E-cadherin and -catenin but
not with -catenin in SCC9 cells. This result suggests that other
proteins such as Pg could mediate the association between E-cadherin
and PKP2a. Because this complex lacks -catenin, it is unlikely to be
found in mature adherens junctions, but it perhaps represents a
junction intermediate involved in sorting and segregation of components
during the early stages of junction formation or during the dynamic
regulation of junctional structures. Even though we were unable to
detect colocalization of endogenous PKP2a and -catenin in SCC9
cells, we did observe extensive colocalization of ectopic PKP2a and its
head domain with endogenous -catenin along the cell borders. It has
been shown previously that there is a pool of -catenin localized in the lateral membrane of Madin-Darby canine kidney cells that does not
contain E-cadherin (53), so possibly ectopic PKP2a could interact with
this pool of -catenin at the membrane but not the E-cadherin bound
pool of -catenin.
Despite a lack of apparent effect on the total level of -catenin,
PKP2a overexpression resulted in a modest, but reproducible increase in
the level of endogenous -catenin/TCF signaling in SW480 cells.
Because we could only achieve about 15% transfection efficiency in
SW480 cells, some moderate effect on -catenin protein level by
expression of PKP2a may not have been detectable in the total cell
population. PKP2a expression did not seem to change the subcellular
localization of -catenin in transfected cells, and experiments using
COS cells and HEK293 cells, which could be transfected at efficiencies
greater than 50%, did not reveal any significant effect by PKP2a
expression on either the total level of -catenin or its partitioning
into different detergent soluble pools (data not shown). These results
suggest that PKP2a modulates -catenin signaling through mechanisms
other than regulating its stability, as have been suggested for several
regulators of -catenin/TCF signaling (54-56). Expression of ectopic
E-cadherin inhibited endogenous -catenin/TCF signaling and
suppressed PKP2a-dependent increases in -catenin/TCF
signaling in SW480 cells. A recent paper presented evidence for the
existence of a small pool of transcriptionally active -catenin among
the much larger pool of cytosolic but transcriptionally inactive
-catenin in SW480 cells (47). Our result is consistent with the
model in which E-cadherin sequesters the transcriptionally active pool
of -catenin and prevents its binding to PKP2a.
The data presented in this study show that PKP2 and PKP1 exhibit
overlapping but distinct properties in their repertoires of binding
partners and functional relationships with DP. These results, coupled
with the observed partially overlapping yet different expression
profiles, suggest specific participation of individual or combinations
of PKPs in creating functionally distinguishable desmosomes that are
tailored for the needs of different tissues or differentiation stages.
The ability to interact with -catenin and modulate its signaling
activity indicates that PKP2a might be involved in other cellular
processes such as the cross-talk between desmosomes and adherens
junctions and the transduction of signals from the cell surface to the nucleus.
 |
ACKNOWLEDGEMENTS |
We thank all those who have generously
contributed antibodies, plasmids, and other reagents, including
M. Amagai, P. Cowin, R. Marsh, R. Brackenbury, J. Stanley, P. McCrea, P. Polakis, J. Nelson, and B. Vogelstein. Thanks also to Yejia
Zhang for assistance in the initial cloning of PKP2, Claudia Horn for
technical assistance in the cloning of yeast two-hybrid constructs
containing the cytoplasmic domains of desmosomal cadherins, and Spiro
Getsios, Lisa Godsel, and Andrew Kowalczyk for helpful discussion and
critical reading of the manuscript.
 |
FOOTNOTES |
*
This work is supported by a R. H. Lurie Baseball Charities
Cancer Fellowship (to X. C.), an Institute for the Promotion of Innovation by Science and Technology-Flanders Fellowship (to
S. B), Deutsche Forschungsgemeinschaft Grant Hal791/3-4 (to M. H.), a
Fund for Scientific Research-Flanders grant (to F. v.-R.), and National Institutes of Health Grants RO1 AR43380, PO1 DE12328 (project
4), and AR41836 (to K. G.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of
Pathology, Northwestern University Medical School, 303 East Chicago
Ave., Chicago, IL 60611. Tel.: 312-503-5300; Fax: 312-503-8240;
E-mail: kgreen@northwestern.edu.
Published, JBC Papers in Press, January 14, 2002, DOI 10.1074/jbc.M108765200
 |
ABBREVIATIONS |
The abbreviations used are:
PKP, plakophilin;
IF, intermediate filament;
Pg, plakoglobin;
Dsg, desmoglein;
Dsc, desmocollin;
DP, desmoplakin;
DPNTP, desmoplakin N-terminal
polypeptide;
IP, immunoprecipitation;
nt, nucleotide(s);
kb, kilobase;
PBS, phosphate-buffered saline;
X- -gal, 5-bromo-4-chloro-3-indolyl
-D-galactopyranoside;
TCF, T cell factor.
 |
REFERENCES |
| 1.
|
Hatzfeld, M.,
Kristjansson, G. I.,
Plessmann, U.,
and Weber, K.
(1994)
J. Cell Sci.
107,
2259-2270[Abstract]
|
| 2.
|
Mertens, C.,
Kuhn, C.,
and Franke, W. W.
(1996)
J. Cell Biol.
135,
1009-1025[Abstract/Free Full Text]
|
| 3.
|
Bonne, S.,
van Hengel, J.,
Nollet, F.,
Kools, P.,
and van Roy, F.
(1999)
J. Cell Sci.
112,
2265-2276[Abstract]
|
| 4.
|
Schmidt, A.,
Langbein, L.,
Pratzel, S.,
Rode, M.,
Rackwitz, H. R.,
and Franke, W. W.
(1999)
Differentiation
64,
291-306[Medline]
[Order article via Infotrieve]
|
| 5.
|
Schmidt, A.,
Langbein, L.,
Rode, M.,
Pratzel, S.,
Zimbelmann, R.,
and Franke, W. W.
(1997)
Cell Tissue Res.
290,
481-499[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Moll, I.,
Kurzen, H.,
Langbein, L.,
and Franke, W. W.
(1997)
J. Invest. Dermatol.
108,
139-146[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Cowin, P.,
and Burke, B.
(1996)
Curr. Opin. Cell Biol.
8,
56-65[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Garrod, D.,
Chidgey, M.,
and North, A.
(1996)
Curr. Opin. Cell Biol.
8,
670-678[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Kowalczyk, A. P.,
Bornslaeger, E. A.,
Norvell, S. M.,
Palka, H. L.,
and Green, K. J.
(1999)
Int. Rev. Cytol.
185,
237-302[Medline]
[Order article via Infotrieve]
|
| 10.
|
Green, K. J.,
and Gaudry, C. A.
(2000)
Nat. Rev. Mol. Cell. Biol.
1,
208-216[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Buxton, R. S.,
Cowin, P.,
Franke, W. W.,
Garrod, D. R.,
Green, K. J.,
King, I. A.,
Koch, P. J.,
Magee, A. I.,
Rees, D. A.,
and Stanley, J. R.
(1993)
J. Cell Biol.
121,
481-483[Free Full Text]
|
| 12.
|
Koch, P. J.,
and Franke, W. W.
(1994)
Curr. Opin. Cell Biol.
6,
682-687[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Ruiz, P.,
Brinkmann, V.,
Ledermann, B.,
Behrend, M.,
Grund, C.,
Thalhammer, C.,
Vogel, F.,
Birchmeier, C.,
Gunthert, U.,
Franke, W. W.,
and Birchmeier, W.
(1996)
J. Cell Biol.
135,
215-225[Abstract/Free Full Text]
|
| 14.
|
Bierkamp, C.,
McLaughlin, K. J.,
Schwarz, H.,
Huber, O.,
and Kemler, R.
(1996)
Dev. Biol.
180,
780-785[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
McKoy, G.,
Protonotarios, N.,
Crosby, A.,
Tsatsopoulou, A.,
Anastasakis, A.,
Coonar, A.,
Norman, M.,
Baboonian, C.,
Jeffery, S.,
and McKenna, W. J.
(2000)
Lancet
355,
2119-2124[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
McGrath, J. A.,
McMillan, J. R.,
Shemanko, C. S.,
Runswick, S. K.,
Leigh, I. M.,
Lane, E. B.,
Garrod, D. R.,
and Eady, R. A.
(1997)
Nat. Genet.
17,
240-244[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Bornslaeger, E. A.,
Godsel, L. M.,
Corcoran, C. M.,
Park, J. K.,
Hatzfeld, M.,
Kowalczyk, A. P.,
and Green, K. J.
(2001)
J. Cell Sci.
114,
727-738[Abstract]
|
| 18.
|
Hatzfeld, M.,
Haffner, C.,
Schulze, K.,
and Vinzens, U.
(2000)
J. Cell Biol.
149,
209-222[Abstract/Free Full Text]
|
| 19.
|
Kowalczyk, A. P.,
Hatzfeld, M.,
Bornslaeger, E. A.,
Kopp, D. S.,
Borgwardt, J. E.,
Corcoran, C. M.,
Settler, A.,
and Green, K. J.
(1999)
J. Biol. Chem.
274,
18145-18148[Abstract/Free Full Text]
|
| 20.
|
Simcha, I.,
Shtutman, M.,
Salomon, D.,
Zhurinsky, J.,
Sadot, E.,
Geiger, B.,
and Ben-Ze'ev, A.
(1998)
J. Cell Biol.
141,
1433-1448[Abstract/Free Full Text]
|
| 21.
|
van Hengel, J.,
Vanhoenacker, P.,
Staes, K.,
and van Roy, F.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
7980-7985[Abstract/Free Full Text]
|
| 22.
|
Charpentier, E.,
Lavker, R. M.,
Acquista, E.,
and Cowin, P.
(2000)
J. Cell Biol.
149,
503-520[Abstract/Free Full Text]
|
| 23.
|
Kolligs, F. T.,
Kolligs, B.,
Hajra, K. M., Hu, G.,
Tani, M.,
Cho, K. R.,
and Fearon, E. R.
(2000)
Genes Dev.
14,
1319-1331[Abstract/Free Full Text]
|
| 24.
|
Hakimelahi, S.,
Parker, H. R.,
Gilchrist, A. J.,
Barry, M., Li, Z.,
Bleackley, R. C.,
and Pasdar, M.
(2000)
J. Biol. Chem.
275,
10905-10911[Abstract/Free Full Text]
|
| 25.
|
Noren, N. K.,
Liu, B. P.,
Burridge, K.,
and Kreft, B.
(2000)
J. Cell Biol.
150,
567-580[Abstract/Free Full Text]
|
| 26.
|
Anastasiadis, P. Z.,
Moon, S. Y.,
Thoreson, M. A.,
Mariner, D. J.,
Crawford, H. C.,
Zheng, Y.,
and Reynolds, A. B.
(2000)
Nat. Cell Biol.
2,
637-644[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Jou, T. S.,
Stewart, D. B.,
Stappert, J.,
Nelson, W. J.,
and Marrs, J. A.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
5067-5071[Abstract/Free Full Text]
|
| 28.
|
Willert, K.,
and Nusse, R.
(1998)
Curr. Opin. Genet. Dev.
8,
95-102[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Wodarz, A.,
and Nusse, R.
(1998)
Annu. Rev. Cell Dev. Biol.
14,
59-88[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Dierick, H.,
and Bejsovec, A.
(1999)
Curr. Top. Dev. Biol.
43,
153-190[Medline]
[Order article via Infotrieve]
|
| 31.
|
Zhurinsky, J.,
Shtutman, M.,
and Ben-Ze'ev, A.
(2000)
J. Cell Sci.
113,
3127-3139[Abstract]
|
| 32.
|
Mertens, C.,
Hofmann, I.,
Wang, Z.,
Teichmann, M.,
Chong, S. S.,
Schnolzer, M.,
and Franke, W. W.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
7795-7800[Abstract/Free Full Text]
|
| 33.
|
Kowalczyk, A. P.,
Palka, H. L.,
Luu, H. H.,
Nilles, L. A.,
Anderson, J. E.,
Wheelock, M. J.,
and Green, K. J.
(1994)
J. Biol. Chem.
269,
31214-31223[Abstract/Free Full Text]
|
| 34.
|
Palka, H. L.,
and Green, K. J.
(1997)
J. Cell Sci.
110,
2359-2371[Abstract]
|
| 35.
|
Bornslaeger, E. A.,
Corcoran, C. M.,
Stappenbeck, T. S.,
and Green, K. J.
(1996)
J. Cell Biol.
134,
985-1001[Abstract/Free Full Text]
|
| 36.
|
Ishii, K.,
Norvell, S. M.,
Bannon, L. J.,
Amargo, E. V.,
Pascoe, L. T.,
and Green, K. J.
(2001)
J. Invest. Dermatol.
117,
26-35[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Stappenbeck, T. S.,
and Green, K. J.
(1992)
J. Cell Biol.
116,
1197-1209[Abstract/Free Full Text]
|
| 38.
|
Angst, B. D.,
Nilles, L. A.,
and Green, K. J.
(1990)
J. Cell Sci.
97,
247-257[Abstract/Free Full Text]
|
| 39.
|
Gaudry, C. A.,
Palka, H. L.,
Dusek, R. L.,
Huen, A. C.,
Khandekar, M. J.,
Hudson, L. G.,
and Green, K. J.
(2001)
J. Biol. Chem.
276,
24871-24880[Abstract/Free Full Text]
|
| 40.
|
Wahl, J. K.,
Sacco, P. A.,
McGranahan-Sadler, T. M.,
Sauppe, L. M.,
Wheelock, M. J.,
and Johnson, K. R.
(1996)
J. Cell Sci.
109,
1143-1154[Abstract]
|
| 41.
|
Norvell, S. M.,
and Green, K. J.
(1998)
J. Cell Sci.
111,
1305-1318[Abstract]
|
| 42.
|
Kowalczyk, A. P.,
Bornslaeger, E. A.,
Borgwardt, J. E.,
Palka, H. L.,
Dhaliwal, A. S.,
Corcoran, C. M.,
Denning, M. F.,
and Green, K. J.
(1997)
J. Cell Biol.
139,
773-784[Abstract/Free Full Text]
|
| 43.
|
Kowalczyk, A. P.,
Navarro, P.,
Dejana, E.,
Bornslaeger, E. A.,
Green, K. J.,
Kopp, D. S.,
and Borgwardt, J. E.
(1998)
J. Cell Sci.
111,
3045-3057[Abstract]
|
| 44.
|
Korinek, V.,
Barker, N.,
Morin, P. J.,
van Wichen, D.,
de Weger, R.,
Kinzler, K. W.,
Vogelstein, B.,
and Clevers, H.
(1997)
Science
275,
1784-1787[Abstract/Free Full Text]
|
| 45.
|
Smith, E. A.,
and Fuchs, E.
(1998)
J. Cell Biol.
141,
1229-1241[Abstract/Free Full Text]
|
| 46.
|
Morin, P. J.,
Sparks, A. B.,
Korinek, V.,
Barker, N.,
Clevers, H.,
Vogelstein, B.,
and Kinzler, K. W.
(1997)
Science
275,
1787-1790[Abstract/Free Full Text]
|
| 47.
|
Gottardi, C. J.,
Wong, E.,
and Gumbiner, B. M.
(2001)
J. Cell Biol.
153,
1049-1060[Abstract/Free Full Text]
|
| 48.
|
Orsulic, S.,
Huber, O.,
Aberle, H.,
Arnold, S.,
and Kemler, R.
(1999)
J. Cell Sci.
112,
1237-1245[Abstract]
|
| 49.
|
Hofmann, I.,
Mertens, C.,
Brettel, M.,
Nimmrich, V.,
Schnolzer, M.,
and Herrmann, H.
(2000)
J. Cell Sci.
113,
2471-2483[Abstract]
|
| 50.
|
Witcher, L. L.,
Collins, R.,
Puttagunta, S.,
Mechanic, S. E.,
Munson, M.,
Gumbiner, B.,
and Cowin, P.
(1996)
J. Biol. Chem.
271,
10904-10909[Abstract/Free Full Text]
|
| 51.
|
Chitaev, N. A.,
Leube, R. E.,
Troyanovsky, R. B.,
Eshkind, L. G.,
Franke, W. W.,
and Troyanovsky, S. M.
(1996)
J. Cell Biol.
133,
359-369[Abstract/Free Full Text]
|
| 52.
|
White, F. H.,
and Gohari, K.
(1984)
J. Cell Sci.
66,
411-429[Abstract]
|
| 53.
|
Nathke, I. S.,
Hinck, L.,
Swedlow, J. R.,
Papkoff, J.,
and Nelson, W. J.
(1994)
J. Cell Biol.
125,
1341-1352[Abstract/Free Full Text]
|
| 54.
|
Young, C. S.,
Kitamura, M.,
Hardy, S.,
and Kitajewski, J.
(1998)
Mol. Cell. Biol.
18,
2474-2485[Abstract/Free Full Text]
|
| 55.
|
Nelson, R. W.,
and Gumbiner, B. M.
(1999)
J. Cell Biol.
147,
367-374[Abstract/Free Full Text]
|
| 56.
|
Guger, K. A.,
and Gumbiner, B. M.
(2000)
Dev. Biol.
223,
441-448[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Getsios, C. L. Simpson, S.-i. Kojima, R. Harmon, L. J. Sheu, R. L. Dusek, M. Cornwell, and K. J. Green
Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis
J. Cell Biol.,
June 29, 2009;
185(7):
1243 - 1258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Bass-Zubek, R. P. Hobbs, E. V. Amargo, N. J. Garcia, S. N. Hsieh, X. Chen, J. K. Wahl III, M. F. Denning, and K. J. Green
Plakophilin 2: a critical scaffold for PKC{alpha} that regulates intercellular junction assembly
J. Cell Biol.,
October 17, 2008;
181(4):
605 - 613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Severs, A. F. Bruce, E. Dupont, and S. Rothery
Remodelling of gap junctions and connexin expression in diseased myocardium
Cardiovasc Res,
October 1, 2008;
80(1):
9 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rohr
Molecular Crosstalk Between Mechanical and Electrical Junctions at the Intercalated Disc
Circ. Res.,
September 28, 2007;
101(7):
637 - 639.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Oxford, H. Musa, K. Maass, W. Coombs, S. M. Taffet, and M. Delmar
Connexin43 Remodeling Caused by Inhibition of Plakophilin-2 Expression in Cardiac Cells
Circ. Res.,
September 28, 2007;
101(7):
703 - 711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Goossens, B. Janssens, S. Bonne, R. De Rycke, F. Braet, J. van Hengel, and F. van Roy
A unique and specific interaction between {alpha}T-catenin and plakophilin-2 in the area composita, the mixed-type junctional structure of cardiac intercalated discs
J. Cell Sci.,
June 15, 2007;
120(12):
2126 - 2136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Kottke, E. Delva, and A. P. Kowalczyk
The desmosome: cell science lessons from human diseases.
J. Cell Sci.,
March 1, 2006;
119(Pt 5):
797 - 806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Dusek, S. Getsios, F. Chen, J. K. Park, E. V. Amargo, V. L. Cryns, and K. J. Green
The Differentiation-dependent Desmosomal Cadherin Desmoglein 1 Is a Novel Caspase-3 Target That Regulates Apoptosis in Keratinocytes
J. Biol. Chem.,
February 10, 2006;
281(6):
3614 - 3624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Syrris, D. Ward, A. Asimaki, S. Sen-Chowdhry, H. Y. Ebrahim, A. Evans, N. Hitomi, M. Norman, A. Pantazis, A. L. Shaw, et al.
Clinical Expression of Plakophilin-2 Mutations in Familial Arrhythmogenic Right Ventricular Cardiomyopathy
Circulation,
January 24, 2006;
113(3):
356 - 364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yin, S. Getsios, R. Caldelari, L. M. Godsel, A. P. Kowalczyk, E. J. Muller, and K. J. Green
Mechanisms of Plakoglobin-dependent Adhesion: DESMOSOME-SPECIFIC FUNCTIONS IN ASSEMBLY AND REGULATION BY EPIDERMAL GROWTH FACTOR RECEPTOR
J. Biol. Chem.,
December 2, 2005;
280(48):
40355 - 40363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Krull, J. Brosius, and J. Schmitz
Alu-SINE Exonization: En Route to Protein-Coding Function
Mol. Biol. Evol.,
August 1, 2005;
22(8):
1702 - 1711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. De Craene, B. Gilbert, C. Stove, E. Bruyneel, F. van Roy, and G. Berx
The Transcription Factor Snail Induces Tumor Cell Invasion through Modulation of the Epithelial Cell Differentiation Program
Cancer Res.,
July 15, 2005;
65(14):
6237 - 6244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhao, B. A. Weir, T. LaFramboise, M. Lin, R. Beroukhim, L. Garraway, J. Beheshti, J. C. Lee, K. Naoki, W. G. Richards, et al.
Homozygous Deletions and Chromosome Amplifications in Human Lung Carcinomas Revealed by Single Nucleotide Polymorphism Array Analysis
Cancer Res.,
July 1, 2005;
65(13):
5561 - 5570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Hardman, K. Liu, A. A. Avilion, A. Merritt, K. Brennan, D. R. Garrod, and C. Byrne
Desmosomal Cadherin Misexpression Alters {beta}-Catenin Stability and Epidermal Differentiation
Mol. Cell. Biol.,
February 1, 2005;
25(3):
969 - 978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Grossmann, C. Grund, J. Huelsken, M. Behrend, B. Erdmann, W. W. Franke, and W. Birchmeier
Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation
J. Cell Biol.,
October 11, 2004;
167(1):
149 - 160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. F. Kelly, C. M. Spring, A. A. Otchere, and J. M. Daniel
NLS-dependent nuclear localization of p120ctn is necessary to relieve Kaiso-mediated transcriptional repression
J. Cell Sci.,
June 1, 2004;
117(13):
2675 - 2686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Cheng, K. Mihindukulasuriya, Z. Den, A. P. Kowalczyk, C. C. Calkins, A. Ishiko, A. Shimizu, and P. J. Koch
Assessment of Splice Variant-Specific Functions of Desmocollin 1 in the Skin
Mol. Cell. Biol.,
January 1, 2004;
24(1):
154 - 163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Chen, S.-i. Kojima, G. G. Borisy, and K. J. Green
p120 catenin associates with kinesin and facilitates the transport of cadherin-catenin complexes to intercellular junctions
J. Cell Biol.,
November 10, 2003;
163(3):
547 - 557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kazerounian and S. Aho
Characterization of Periphilin, a Widespread, Highly Insoluble Nuclear Protein and Potential Constituent of the Keratinocyte Cornified Envelope
J. Biol. Chem.,
September 19, 2003;
278(38):
36707 - 36717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. South, H. Wan, M. G. Stone, P. J. C. Dopping-Hepenstal, P. E. Purkis, J. F. Marshall, I. M. Leigh, R. A. J. Eady, I. R. Hart, and J. A. McGrath
Lack of plakophilin 1 increases keratinocyte migration and reduces desmosome stability
J. Cell Sci.,
August 15, 2003;
116(16):
3303 - 3314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bonne, B. Gilbert, M. Hatzfeld, X. Chen, K. J. Green, and F. van Roy
Defining desmosomal plakophilin-3 interactions
J. Cell Biol.,
April 28, 2003;
161(2):
403 - 416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hatzfeld, K. J. Green, and H. Sauter
Targeting of p0071 to desmosomes and adherens junctions is mediated by different protein domains
J. Cell Sci.,
April 1, 2003;
116(7):
1219 - 1233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Fleet, L. Wang, O. Vitek, B. A. Craig, and H. J. Edenberg
Gene expression profiling of Caco-2 BBe cells suggests a role for specific signaling pathways during intestinal differentiation
Physiol Genomics,
March 18, 2003;
13(1):
57 - 68.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Calkins, B. L. Hoepner, C. M. Law, M. R. Novak, S. V. Setzer, M. Hatzfeld, and A. P. Kowalczyk
The Armadillo Family Protein p0071 Is a VE-cadherin- and Desmoplakin-binding Protein
J. Biol. Chem.,
January 10, 2003;
278(3):
1774 - 1783.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|